Results 261 to 270 of about 13,011 (272)

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

Blood, 2006
Maria Domenica Cappellini, Alan R Cohen, Antonio Piga   +2 more
exaly  

The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

Journal of Antimicrobial Chemotherapy, 2012
Ashraf S Ibrahim, Peter V Chin-Hong, Dimitrios P Kontoyiannis   +2 more
exaly  

Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

Blood, 2006
Ellis J Neufeld
exaly  

Deferasirox, a trivalent iron chelator, ameliorates neuronal damage in hemorrhagic stroke models

Naunyn-Schmiedeberg's Archives of Pharmacology, 2020
Takahiko Imai, Shohei Tsuji, Hirohumi Matsubara, Takuya Ohba, Tomoki Sugiyama, Shinsuke Nakamura, H. Hara, M. Shimazawa   +7 more
semanticscholar   +1 more source

Sugar-conjugated dendritic mesoporous silica nanoparticles as pH-responsive nanocarriers for tumor targeting and controlled release of deferasirox

Materials Science and Engineering C, 2019
Arezoo Sodagar Taleghani, Pedram Ebrahimnejad, Azim Akbarzadeh   +2 more
exaly  

A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis

Hepatology, 2010
Herbert L Bonkovsky, Alberto Piperno, Antonello Pietrangelo   +2 more
exaly  

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Blood, 2011
Alan R Cohen, Antonis Kattamis, Silverio Perrotta   +2 more
exaly  

Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study

European Journal of Haematology, 2008
John B Porter, Giuseppe Saglio, Ellis J Neufeld   +2 more
exaly  

Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia

Blood, 2010
Dudley J Pennell, John B Porter, Maria Domenica Cappellini   +2 more
exaly  

The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers

Journal of Pathology, 2018
Sandrine Tury, Sophie Vacher, David Gentien   +2 more
exaly